Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,579.58
(
0.21%
)
US TECH 100
29,493.20
(
0.24%
)
Dow Jones
50,981.72
(
0.62%
)
Brent Oil
91.28
(
-0.98%
)
Bitcoin
73,339.41
(
-0.29%
)
News Focus
News Focus
Post# of 9396
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

MartinLutherKing

Send PM Follow Ignore
Followers 75
Posts 4493
Boards Moderated 0
Alias Born 04/08/2022

MartinLutherKing

Re: zj3001 post# 4831

Saturday, 10/12/2024 9:54:34 PM

Saturday, October 12, 2024 9:54:34 PM

Post# of 9396
TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique, well-documented biomarker of metastasis. In addition, TransCode is developing a portfolio of other first-in-class RNA therapeutic candidates designed to overcome the challenges of RNA delivery and thus unlock therapeutic access to a variety of novel genetic targets that could be relevant to treating a variety of cancers.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent RNAZ News
More RNAZ News